AEROVATE THERAPEUTICS INC's ticker is AVTE and the CUSIP is 008064107. A total of 67 filers reported holding AEROVATE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,192,215 | -20.9% | 1,561,696 | 0.0% | 1.24% | -17.6% |
| Q2 2023 | $26,783,086 | +84928.4% | 1,561,696 | 0.0% | 1.50% | -27.7% |
| Q1 2023 | $31,499 | -45.1% | 1,561,696 | -20.2% | 2.07% | -45.9% |
| Q4 2022 | $57,344 | -99.9% | 1,957,132 | -16.0% | 3.84% | +42.1% |
| Q3 2022 | $38,643,000 | +42.9% | 2,330,691 | +34.7% | 2.70% | +32.1% |
| Q2 2022 | $27,051,000 | -19.4% | 1,730,691 | -5.5% | 2.04% | -20.6% |
| Q1 2022 | $33,557,000 | +55.5% | 1,830,691 | 0.0% | 2.58% | +100.6% |
| Q4 2021 | $21,584,000 | -48.6% | 1,830,691 | -9.8% | 1.28% | -24.7% |
| Q3 2021 | $41,962,000 | -5.9% | 2,030,691 | 0.0% | 1.70% | +12.5% |
| Q2 2021 | $44,613,000 | – | 2,030,691 | – | 1.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OUP Management Co., LLC | 603,762 | $17,690,227 | 28.88% |
| Atlas Venture Life Science Advisors, LLC | 2,017,521 | $59,113,365 | 7.12% |
| Sofinnova Investments, Inc. | 3,758,686 | $110,129,500 | 6.54% |
| TCG Crossover Management, LLC | 1,081,274 | $31,681,328 | 5.59% |
| RA Capital Management | 8,263,982 | $242,134,673 | 4.91% |
| Cormorant Asset Management, LP | 1,957,132 | $57,344 | 3.84% |
| VR Adviser, LLC | 747,869 | $21,912,562 | 3.69% |
| Octagon Capital Advisors LP | 621,712 | $18,216,162 | 2.84% |
| GREAT POINT PARTNERS LLC | 378,522 | $11,090,695 | 2.17% |
| Ghost Tree Capital, LLC | 135,000 | $3,956,000 | 1.69% |